David Annis
Chief Tech/Sci/R&D Officer en AILERON THERAPEUTICS, INC. .
Fortuna: 2 500 $ al 31/03/2024
Perfil
David Allen Annis is currently the Senior Vice President-Research at Aileron Therapeutics, Inc. He previously worked as the Director-Technology Development at Schering-Plough Research Institute and as the Vice President-New Technologies at NeoGenesis Pharmaceuticals, Inc. Dr. Annis received his graduate and doctorate degrees from Harvard University and his undergraduate degree from Georgia Institute of Technology.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/11/2023 | 377 ( 0.01% ) | 2 500 $ | 31/03/2024 |
Cargos activos de David Annis
| Empresas | Cargo | Inicio |
|---|---|---|
| AILERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05/11/2018 |
Antiguos cargos conocidos de David Annis.
| Empresas | Cargo | Fin |
|---|---|---|
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Corporate Officer/Principal | - |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Formación de David Annis.
| Harvard University | Doctorate Degree |
| Georgia Institute of Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AILERON THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- David Annis
